AU6763496A - Treatment of ocular inflammatory conditions with interleukin-10 - Google Patents

Treatment of ocular inflammatory conditions with interleukin-10

Info

Publication number
AU6763496A
AU6763496A AU67634/96A AU6763496A AU6763496A AU 6763496 A AU6763496 A AU 6763496A AU 67634/96 A AU67634/96 A AU 67634/96A AU 6763496 A AU6763496 A AU 6763496A AU 6763496 A AU6763496 A AU 6763496A
Authority
AU
Australia
Prior art keywords
interleukin
treatment
inflammatory conditions
ocular inflammatory
ocular
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU67634/96A
Other languages
English (en)
Inventor
Stephen M. Boorstein
Susan G. Elner
Victor M. Elner
Robert N. Lausch
John E. Oakes
Terrence M. Tumpey
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Merck Sharp and Dohme Corp
Original Assignee
Schering Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering Corp filed Critical Schering Corp
Publication of AU6763496A publication Critical patent/AU6763496A/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19—Cytokines; Lymphokines; Interferons
    • A61K38/20—Interleukins [IL]
    • A61K38/2066—IL-10
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Ophthalmology & Optometry (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Epidemiology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AU67634/96A 1995-08-07 1996-08-05 Treatment of ocular inflammatory conditions with interleukin-10 Abandoned AU6763496A (en)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US199495P 1995-08-07 1995-08-07
US001994 1995-08-07
US62972196A 1996-04-09 1996-04-09
US629721 1996-04-09
PCT/US1996/012459 WO1997005895A1 (fr) 1995-08-07 1996-08-05 Traitement d'inflammations oculaires avec de l'interleukine-10

Publications (1)

Publication Number Publication Date
AU6763496A true AU6763496A (en) 1997-03-05

Family

ID=26669772

Family Applications (1)

Application Number Title Priority Date Filing Date
AU67634/96A Abandoned AU6763496A (en) 1995-08-07 1996-08-05 Treatment of ocular inflammatory conditions with interleukin-10

Country Status (5)

Country Link
EP (1) EP0847277A1 (fr)
JP (1) JPH11510185A (fr)
AU (1) AU6763496A (fr)
CA (1) CA2228620A1 (fr)
WO (1) WO1997005895A1 (fr)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU718857B2 (en) * 1996-05-03 2000-04-20 Schering Corporation Method for treating inflammation

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2348488C (fr) * 1999-01-05 2011-03-01 The Flinders University Of South Australia Nouveaux agents et methodes pour le traitement et le diagnostic de troubles oculaires
DE60228431D1 (de) * 2001-03-28 2008-10-02 Santen Pharmaceutical Co Ltd Heilmittel für erkrankungen der retina und der aderhaut die als aktive bestandteile steroide enthalten
WO2009102715A2 (fr) * 2008-02-11 2009-08-20 Board Of Supervisors Of Louisiana State University And Agricultural And Mechanical College Thérapie à base peptidique contre les infections oculaires à virus herpes

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2145863A1 (fr) * 1992-10-01 1994-04-28 Martha W. Bond Utilisation prophylactique ou therapeutique de l'il-10 dans les cas de diabete sucre insulinodependant
AU7043694A (en) * 1993-05-27 1994-12-20 Regents Of The University Of Michigan, The Method of treatment and prevention of immune complex-induced lung injury

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU718857B2 (en) * 1996-05-03 2000-04-20 Schering Corporation Method for treating inflammation

Also Published As

Publication number Publication date
EP0847277A1 (fr) 1998-06-17
WO1997005895A1 (fr) 1997-02-20
MX9801038A (es) 1998-05-31
CA2228620A1 (fr) 1997-02-20
JPH11510185A (ja) 1999-09-07

Similar Documents

Publication Publication Date Title
AUPM864894A0 (en) Treatment of bowel-dependent neurological disorders
AU3548795A (en) Benzopyranopyrazolyl derivatives for the treatment of inflammation
AU3441197A (en) 3-ureido-pyridofurans and -pyridothiophenes for the treatment of inflammatory processes
AU5860396A (en) Substituted oxazoles for the treatment of inflammation
AU7905894A (en) Treatment of poultry
AU1173195A (en) Treatment of immunoregulatory disorders
EP0820286A4 (fr) Traitement d'inflammations oculaires
AU1115095A (en) Treatment of cellulose
AU4131296A (en) Treatment of disorders with duloxetine
AU2424895A (en) Substituted spirodienes for the treatment of inflammation
AU4224096A (en) Use of phenylcyclohexylcarboxamides
AU6927894A (en) 4-amidinophenylsulphonamides for the treatment of thrombo-embolitic conditions
AU4220193A (en) Deazaaminopterins for treatment of inflammation
AU6763496A (en) Treatment of ocular inflammatory conditions with interleukin-10
AU1249395A (en) Topical treatment of ocular photophobia
AU3518695A (en) Gene therapy for transplantation and inflammatory or thrmbotic conditions
AU2705195A (en) Incontinence treatment
AU6829696A (en) Treatment of solutions
AU5699396A (en) Compositions for the treatment of skin conditions
AU2754997A (en) The treatment of plant diseases
AU7113996A (en) Methods of treating beta-amyloid-associated conditions
AU9082798A (en) Treatment of inflammatory conditions
AU6171196A (en) Therapeutic uses of ta99
AU1370397A (en) Process for the purification of recombinant human interleukin-8
AU4119993A (en) Heteroaroyl-10-deazaaminopterins for treatment of inflammation